Last reviewed · How we verify
Peginterferon α-2b based treatment group
Peginterferon α-2b based treatment group is a Small molecule drug developed by Qing XIe. It is currently in Phase 1 development.
At a glance
| Generic name | Peginterferon α-2b based treatment group |
|---|---|
| Sponsor | Qing XIe |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B (PHASE4)
- A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis (NA)
- Effects of Peginterferon Consolidation Therapy on Hepatic cccDNA Dynamics in CHB Patients Achieving Clinical Cure. (NA)
- Peginterferon α-2b Injection for the Treatment of Pediatric RSV Bronchiolitis (NA)
- Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata (NA)
- Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study） (NA)
- Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Peginterferon α-2b based treatment group CI brief — competitive landscape report
- Peginterferon α-2b based treatment group updates RSS · CI watch RSS
- Qing XIe portfolio CI
Frequently asked questions about Peginterferon α-2b based treatment group
What is Peginterferon α-2b based treatment group?
Peginterferon α-2b based treatment group is a Small molecule drug developed by Qing XIe.
Who makes Peginterferon α-2b based treatment group?
Peginterferon α-2b based treatment group is developed by Qing XIe (see full Qing XIe pipeline at /company/qing-xie).
What development phase is Peginterferon α-2b based treatment group in?
Peginterferon α-2b based treatment group is in Phase 1.